|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: April 2024
Volume 9 | Issue 4
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 95
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Formulation & Evaluation Of Rauwolfia Serpentina Tablet For Anti-Hypertensive Effect |
| Authors Name: | Chincholkar Pranjali , Ms.A.S.Sanap , Dr.Prachi Udapurkar |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_197807
|
| Published Paper Id: | IJNRD2306053 |
| Published In: | Volume 8 Issue 6, June-2023 |
| DOI: | |
| Abstract: | Abstract:- Rauwolfia serpentina is an Indian medicinal plant and is a safe and effective treatment for poisonous reptiles,Hypertention,Cancer etc . The plant was used by many physicians throughout India in the 1940s and then was used throughout the world in the 1950. In this review we focus on the use of Rauwolfia and treatment for High Blood pressure, its botany, chemistry and mode of action with special emphasis on the plants role in treating high blood pressure and hypertension, and also critically examining its adverse side effects, toxicology and carcinogenicity. Rauwolfia Serpentina Tablet are reported to contain Variety of Alkaloids constituents and hence widely used for the treatment of Hypertension. The present investigation was aimed to formulate Tablet formulations containing Rauwolfia in order to obtain antihypertension formulations with more effective oral activity, less side effects, increased patient compliance thereby providing multifaceted benefits.. |
| Keywords: | |
| Cite Article: | "Formulation & Evaluation Of Rauwolfia Serpentina Tablet For Anti-Hypertensive Effect", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 6, page no.a487-a494, June-2023, Available :http://www.ijnrd.org/papers/IJNRD2306053.pdf |
| Downloads: | 000118751 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2306053 Registration ID: 197807 Published In: Volume 8 Issue 6, June-2023 DOI (Digital Object Identifier): Page No: a487-a494 Country: YAVATMAL, MAHARASHTRA , India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2306053 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2306053 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn